31 completed, 1 terminated. 32 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 32 | Completed 31, Terminated 1 |
Follow Warner Chilcott: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia WC3011 Estradiol Vaginal Cream, Vehicle - Vulvovaginal Atrophy | Phase 3 | Completed | Warner Chilcott | 550 | 2013-04-12 | 2022-05-09 |
| Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women Vehicle, WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy | Phase 3 | Completed | Warner Chilcott | 576 | 2013-01-31 | 2022-05-09 |
| Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy | Phase 3 | Completed | Warner Chilcott | 309 | 2011-10-20 | 2022-05-09 |
| Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women WC3011 Estradiol Vaginal Cream, Vehicle - Postmenopausal Vulvovaginal Atrophy | Phase 3 | Completed | Warner Chilcott | 722 | 2011-06-29 | 2022-05-09 |
| Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin Doxycyline Hyclate tablet, Vibramycin (doxycyline hyclate) capsule - Urogential Chlamydia Trachomatis Infection | Phase 3 | Completed | Warner Chilcott | 495 | 2010-04-01 | 2012-01-27 |
| Treatment of Erectile Dysfunction - Long Term Safety and Efficacy Udenafil 50 mg, Udenafil 100 mg, Udenafil 150 mg - Erectile Dysfunction | Phase 3 | Completed | Warner Chilcott | 1027 | 2010-01-01 | 2015-04-20 |
| Assessing the Safety/Efficacy of AsacolĀ® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis Asacol 400 mg - Ulcerative Colitis | Phase 3 | Terminated | Warner Chilcott | 39 | 2009-10-01 | 2012-05-25 |
| Treatment of Erectile Dysfunction II Udenafil, Placebo - Erectile Dysfunction | Phase 3 | Completed | Warner Chilcott | 601 | 2009-09-01 | 2015-06-19 |
| Treatment of Erectile Dysfunction I Udenafil, Placebo - Erectile Dysfunction | Phase 3 | Completed | Warner Chilcott | 618 | 2009-09-01 | 2011-12-22 |
| Assessing the Safety/Efficacy of AsacolĀ® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis Asacol 400 mg - Ulcerative Colitis | Phase 3 | Completed | Warner Chilcott | 83 | 2008-12-01 | 2012-04-05 |
| A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis risedronate - Postmenopausal Osteoporosis | Phase 3 | Completed | Warner Chilcott | 923 | 2007-10-01 | 2013-04-22 |
| A Comparison of Once a Day Dose Compared to 2 Doses/Day Mesalamine Once-Daily, Mesalamine Twice-Daily - Ulcerative Colitis | Phase 3 | Completed | Warner Chilcott | 1027 | 2007-07-01 | 2013-04-22 |
| Study of Safety and Efficacy of an Oral Contraceptive Norethindrone/ethinyl estradiol - Contraception | Phase 3 | Completed | Warner Chilcott | 1700 | 2007-06-01 | 2013-04-22 |
| Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women Testosterone Transdermal System, Placebo patch - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | Warner Chilcott | 1271 | 2007-04-01 | 2011-12-15 |
| Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen Testosterone, Placebo - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | Warner Chilcott | 272 | 2006-11-01 | 2013-04-17 |
| Study of Safety and Efficacy of an Oral Contraceptive Norethindrone acetate/ethinyl estradiol - Contraception | Phase 3 | Completed | Warner Chilcott | 1683 | 2006-11-01 | 2013-04-22 |
| A Double Blind Study for the Treatment of Acute Ulcerative Colitis Mesalamine - Ulcerative Colitis | Phase 3 | Completed | Warner Chilcott | 772 | 2006-06-01 | 2013-04-17 |
| Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method Placebo comparator, risedronate - Osteopenia | Phase 3 | Completed | Warner Chilcott | 161 | 2006-04-01 | 2012-01-11 |
| A Study of Monthly Risedronate for Osteoporosis risedronate - Postmenopausal Osteoporosis | Phase 3 | Completed | Warner Chilcott | 1294 | 2005-10-01 | 2013-04-22 |
| Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children risedronate sodium (Actonel), Placebo - Osteogenesis Imperfecta | Phase 3 | Completed | Warner Chilcott | 143 | 2004-11-01 | 2013-04-22 |
Showing 20 of 32. Sign in to see all of them.
Sexual Dysfunctions, Psychological (7) · Colitis, Ulcerative (6) · Erectile Dysfunction (3) · Osteoporosis, Postmenopausal (3) · Osteoporosis (2) · Bone Diseases, Metabolic (1) · Chlamydia Infections (1) · Dyspareunia (1) · Inflammatory Bowel Diseases (1) · Osteogenesis Imperfecta (1)
Risedronic Acid (7) · Mesalamine (5) · udenafil (3) · Ethinyl Estradiol (2) · Norethindrone Acetate (2) · Testosterone (2) · Capsules (1) · Doxycycline (1) · Estradiol (1) · Estrogens, Conjugated (USP) (1) · ovcon 35 (1)
United States (27) · Canada (12) · Australia (11) · Poland (9) · Belgium (5) · Hungary (5) · France (4) · Spain (4) · United Kingdom (4) · Argentina (3) · Croatia (3) · Czechia (3) · Estonia (3) · Finland (3) · Germany (3)
Herman Ellman, MD (8) · Anna Chan, PharmD (4) · Johna Lucas, MD (4) · Dietrich H Wenderoth, MD (2) · Piotr Krzeski, MD (2) · Ana Balske, MD, PhD (1) · Dietrich Wenderoth, MD (1) · Gioacchino D'Alo, MD (1) · Herman Ellman (1) · Imran A Lodhi, MD (1) · Jeffery Kralstein, MD (1) · John Caminis, MD (1) · Johna Lucus, MD (1) · Preston M Dunnmon, MD (1) · Sal Bartelmo, MD (1)
PMID 21255059, PMID 21385195, PMID 18987368, PMID 20064514, PMID 21947137, PMID 22431798, PMID 22750403, PMID 23921878, PMID 23927913, PMID 25419597, PMID 26410176